Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 96, Issue 11, 2005, Pages 1563-1567

  Araujo, Aloir Queiroz ^a   Arteaga, Edmundo ^a   Ianni, Barbara Maria ^a   Buck, Paula Cassia ^a   Rabello, Rogerio ^a   Mady, Charles ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; LOSARTAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLE; DOPPLER FLOWMETRY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL; HEART MUSCLE FIBROSIS; HEART SIZE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; MALE; MITRAL VALVE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CARDIOMYOPATHY, HYPERTROPHIC; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; LOSARTAN; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 28044470767     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.07.065     Document Type: Article

References (22)

1. H. Kawano, Y.S. Do, Y. Kawano, V. Starnes, M. Barr, R.E. Law, W.A. Hsueh Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts Circulation 101 2000 1130 1137
2. B. Schieffer, A. Wirger, M. Meybrunn, S. Seitz, J. Holtz, U.N. Riede, H. Drexler Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat Circulation 89 1994 2273 2282
3. J. Diez, R. Querejeta, B. Lopez, A. Gonzalez, M. Larman, J.L. Martinez Ubago Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients Circulation 105 2002 2512 2517
4. P.A. Thurmann, P. Kenedi, A. Schmidt, S. Harder, N. Rietbrock Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension Circulation 98 1998 2037 2042
5. K. Dickstein, P. Chang, R. Willenheimer, S. Haunso, J. Remes, C. Hall, J. Kjekshus Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe heart failure J Am Coll Cardiol 26 1995 438 445
6. B. Pitt, P.A. Poole-Wilson, R. Segal, F.A. Martinez, K. Dickstein, A.J. Camm, M.A. Konstam, G. Riegger, G.H. Klinger, J. Neaton Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial: the Losartan Heart Failure Survival Study ELITE II Lancet 255 2000 1582 1587
7. K. Masutomo, N. Makino, M.S. Fushiki Effects of losartan on the collagen degradative enzymes in hypertrophic and congestive types of cardiomyopathic hamsters Mol Cell Biochem 224 2001 19 27
8. D.S. Lim, S. Lutucuta, P. Bachireddy, K. Youker, A. Evans, M. Entman, R. Roberts, A.J. Marian Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy Circulation 103 2001 789 791
9. D.J. Sahn, A. DeMaria, J. Kisslo, A. Weyman Recommendations regarding quantification in M-mode echocardiography results of a survey of echocardiographic maeasurements Circulation 58 1978 1072 1083
10. H. Rakowski, C. Appleton, K.L. Chan, J.G. Dumesnil, G. Honos, J. Jue, C. Koilpillai, S. Lepage, R.P. Martin, L.A. Mercier Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography J Am Soc Echocardiogr 9 1996 736 760
11. A.Q. Araujo, E. Arteaga, P.C. Buck, J. Leao, C. Mady Plasma NT-proBNP is elevated in adults with sickle cell disease without clinical heart failure J Card Fail 10 suppl 2004 S41
12. P.S. Douglas The left atrium a biomarker of chronic diastolic dysfunction and cardiovascular disease risk J Am Coll Cardiol 42 2003 1206 1207
13. M.J. Garcia, J.D. Thomas, A.L. Klein New Doppler echocardiographic applications for the study of diastolic function J Am Coll Cardiol 32 1998 865 875
14. S.F. Nagueh, K.J. Middleton, H.A. Kopelen, W.A. Zoghbi, M.A. Quinones Doppler tissue imaging a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures J Am Coll Cardiol 30 1997 1527 1533
15. S.F. Nagueh, L.L. Bachinski, D. Meyer, R. Hill, W.A. Zoghbi, J.W. Tam, M.A. Quinones, R. Roberts, A.J. Marian Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy Circulation 104 2001 128 130
16. C.J. McMahon, S.F. Nagueh, R.H. Pignatelli, S.W. Denfield, W.J. Dreyer, J.F. Price, S. Clunie, L.I. Bezold, A.L. Hays, J.A. Towbin Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy Circulation 109 2004 1756 1762
17. E. Lubien, A. DeMaria, P. Krishnaswamy, P. Clopton, J. Koon, R. Kazanegra, N. Gardetto, E. Wanner, A.S. Maisel Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings Circulation 105 2002 595 601
18. C. Briguori, S. Betocchi, F. Manganelli, B. Gigante, M.A. Losi, Q. Ciampi, R. Gottilla, A. Violante, C.G. Tocchetti, M. Volpe Determinants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy Eur Heart J 22 2001 1328 1336
19. B.J. Maron, V.N. Tholakanahalli, A.G. Zenovich, S.A. Casey, D. Duprez, D.M. Aeppli, J.N. Cohn Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy Circulation 109 2004 984 989
20. C. Hall Essential biochemistry and physiology of (NT-pro) BNP Eur J Heart Fail 6 2004 257 260
21. R. Pfister, M. Scholz, K. Wielckens, E. Erdmann, C.A. Schneider Use of NT-proBNP in routine testing and comparison to BNP Eur J Heart Fail 6 2004 289 293
22. Arteaga E, Araujo AQ, Buck PC, Ianni BM, Rabello R, Mady C. Plasma NT-proBNP quantification in hypertrophic cardiomyopathy. Am Heart J. In press.